Buckysomes: New Nanocarriers for Anticancer Drugs

Figure 3

Organ biodistribution of Abraxane and paclitaxel in paclitaxel-embedded buckysomes at 15, 30, 45, 60, and 180 minutes after tail vein injection in ICR mice. The dose administered was 0.2 mg Abraxane/paclitaxel/mL. The results are expressed as the mean ± S.E. (𝑛=3 for Abraxane, 𝑛=5 for PEB). ^∗𝑃<0.0001 versus control; ^∗∗𝑃<0.05 versus control.

(a)

(b)

(c)

(d)

(e)

(f)